Swiss biotech company Roivant Sciences to go public via $7.3B SPAC deal
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
705 articles · Health Tech & Medtech
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.
Sencure claims to develop chips that help measure electrophysiological parameters on the human body in innovative ways.
Spiden uses optical and AI-based technology to analyse blood, urine, and other body fluids for the first time non-destructively and in real-time.
With Kry’s app, you can meet a doctor or therapist at any time or location, using your phone or tablet.
Onward creates innovative therapies to restore movement, independence, and health in people with spinal cord injury.
Based out of Paris, Alan is a digital health insurance platform that offers insurance services by focusing on a price-quality ratio health plan.
Lumicks is a next-generation life science tools company that develops single-molecule analysis technologies for cancer research and cancer immunotherapy.
Redmond tech giant Microsoft has made its second-biggest acquisition after LinkedIn.
Doctify is an online platform that allows patients to review, choose, and book appointments with doctors.
HealthHero, with this acquisition, aims to be the largest telehealth provider in Europe.
Shop Apotheke Europe has acquired 100 per cent of the shares from the founders of MedApp and investors including Health Innovation Fund III.
Manual claims to challenge the outdated notion that real men shrug their shoulders and carry on.